Dynavax Technologies | Kortsiktig Gjeld

Current Liabilities Endring Dato
AbbVie USD 41.52B 6.75B 2024-03
Adma Biologics USD 53.09M 3.28M 2024-03
Amgen USD 19.71B 1.32B 2024-03
AstraZeneca USD 28.9B 1.64B 2024-03
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Dynavax Technologies USD 56M 6.19M 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
Glaxosmithkline GBP 19.85B 1.22B 2024-03
Merck USD 25.1B 2.01B 2024-03
Neurocrine Biosciences USD 712.9M 21.3M 2024-03
Novartis USD 29.29B 2.9B 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Roche Holding CHF 24.82B 1.38B 2023-12
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
TG Therapeutics USD 99.68M 42.01M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



Dynavax Technologies Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.